New Insights into Drug-Resistant Prostate Cancer

New research from the University of Eastern Finland sheds light on combatting drug-resistant prostate cancer by targeting the glucocorticoid receptor. Limiting the activity of coregulator proteins could prevent the development of drug resistance, offering potential new treatment strategies for this challenging cancer type.